Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-001495-18Phase 4Completed
Phase 4, randomised trial of methylprednisolone sodium succinate in cardiac surgery and cardiac morbidity (2 arms), sponsored by Population Health Research Institute. Primary endpoint: 30-day all-cause mortality. Started Jul 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-001495-18.